# Avalo Therapeutics, Inc.: filings

AVTX · Nasdaq · CIK 1534120 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/avtx.md) · [Financials](/companies/avtx/financials.md) · [Filings](/companies/avtx/filings.md) · [Insiders](/companies/avtx/insiders.md)

## Reports and events: 313 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 485, 8-K 201, 3 62, 424B3 59, SCHEDULE 13G/A 39, 10-Q 33, SC 13D/A 29, CORRESP 28, UPLOAD 24, SCHEDULE 13G 21, 424B5 18, SC 13G 18, SC 13G/A 18, 144 16, S-8 16, EFFECT 15, 8-K/A 13, DEFA14A 13, 10-K 11, DEF 14A 11, S-3 11, D 6, PRE 14A 6, CT ORDER 5, S-3/A 5, ARS 4, S-1/A 4, 10-K/A 3, 10-Q/A 3, 25-NSE 3, 425 3, 4/A 3, DRSLTR 3, FWP 3, SC 13D 3, DRS/A 2, S-1 2, 424B4 1, 8-A12B 1, CERTNAS 1, DEFR14A 1, DRS 1, POS AM 1, PRER14A 1, S-4 1, S-4/A 1, S-8 POS 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-06 | 07:03 ET | [10-Q](/filings/0001534120-26-000049.md) | Quarterly report, period 2026-06-30 | 0001534120-26-000049 |
| 2026-08-06 | 07:01 ET | [8-K](/filings/0001534120-26-000048.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001534120-26-000048 |
| 2026-06-23 | 07:01 ET | [8-K](/filings/0001534120-26-000044.md) | 5.02 Departure or appointment of officers or directors | 0001534120-26-000044 |
| 2026-06-16 | 07:18 ET | [8-K](/filings/0001534120-26-000042.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001534120-26-000042 |
| 2026-06-12 | 16:06 ET | [8-K](/filings/0001534120-26-000040.md) | 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001534120-26-000040 |
| 2026-06-08 | 16:19 ET | [8-K](/filings/0001534120-26-000036.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001534120-26-000036 |
| 2026-05-13 | 07:02 ET | [10-Q](/filings/0001534120-26-000033.md) | Quarterly report, period 2026-03-31 | 0001534120-26-000033 |
| 2026-05-13 | 07:00 ET | [8-K](/filings/0001534120-26-000032.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001534120-26-000032 |
| 2026-05-07 | 19:38 ET | [8-K](/filings/0001104659-26-056482.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-056482 |
| 2026-05-05 | 16:01 ET | [8-K](/filings/0001534120-26-000028.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001534120-26-000028 |
| 2026-04-28 | 07:01 ET | [8-K](/filings/0001534120-26-000026.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001534120-26-000026 |
| 2026-04-10 | 16:01 ET | [DEF 14A](/filings/0001534120-26-000022.md) | Proxy statement, period 2026-04-10 | 0001534120-26-000022 |
| 2026-03-27 | 16:01 ET | [8-K](/filings/0001534120-26-000016.md) | 5.02 Departure or appointment of officers or directors | 0001534120-26-000016 |
| 2026-03-23 | 07:02 ET | [10-K](/filings/0001534120-26-000011.md) | Annual report, period 2025-12-31 | 0001534120-26-000011 |
| 2026-03-23 | 07:01 ET | [8-K](/filings/0001534120-26-000010.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001534120-26-000010 |
| 2026-01-12 | 07:53 ET | [8-K](/filings/0001534120-26-000003.md) | 2.02 Results of operations; 8.01 Other events | 0001534120-26-000003 |
| 2025-12-02 | 06:38 ET | [8-K](/filings/0001534120-25-000022.md) | 8.01 Other events | 0001534120-25-000022 |
| 2025-11-06 | 07:04 ET | [10-Q](/filings/0001534120-25-000018.md) | Quarterly report, period 2025-09-30 | 0001534120-25-000018 |
| 2025-11-06 | 07:02 ET | [8-K](/filings/0001534120-25-000017.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001534120-25-000017 |
| 2025-10-29 | 07:04 ET | [8-K](/filings/0001534120-25-000013.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001534120-25-000013 |
| 2025-10-10 | 07:01 ET | [8-K](/filings/0001534120-25-000011.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001534120-25-000011 |
| 2025-10-01 | 07:01 ET | [8-K](/filings/0001534120-25-000009.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001534120-25-000009 |
| 2025-09-22 | 07:01 ET | [8-K](/filings/0001534120-25-000005.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001534120-25-000005 |
| 2025-08-07 | 07:04 ET | [10-Q](/filings/0001628280-25-038575.md) | Quarterly report, period 2025-06-30 | 0001628280-25-038575 |
| 2025-08-07 | 07:02 ET | [8-K](/filings/0001628280-25-038570.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-038570 |
| 2025-06-20 | 07:08 ET | [8-K](/filings/0001628280-25-032232.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-032232 |
| 2025-06-18 | 07:01 ET | [8-K](/filings/0001628280-25-032011.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-032011 |
| 2025-06-17 | 16:01 ET | [8-K](/filings/0001628280-25-031818.md) | 5.07 Shareholder vote results | 0001628280-25-031818 |
| 2025-06-05 | 16:10 ET | [8-K](/filings/0001628280-25-029639.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001628280-25-029639 |
| 2025-06-04 | 07:01 ET | [8-K](/filings/0001628280-25-029225.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-029225 |
| 2025-05-12 | 07:03 ET | [10-Q](/filings/0001628280-25-024436.md) | Quarterly report, period 2025-03-31 | 0001628280-25-024436 |
| 2025-05-12 | 07:01 ET | [8-K](/filings/0001628280-25-024435.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-024435 |
| 2025-05-08 | 07:02 ET | [8-K](/filings/0001628280-25-023442.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-023442 |
| 2025-05-01 | 07:00 ET | [DEF 14A](/filings/0001628280-25-021311.md) | Proxy statement, period 2025-06-17 | 0001628280-25-021311 |
| 2025-03-26 | 07:01 ET | [8-K](/filings/0001628280-25-014833.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-014833 |
| 2025-03-20 | 07:06 ET | [10-K](/filings/0001628280-25-013986.md) | Annual report, period 2024-12-31 | 0001628280-25-013986 |
| 2025-03-20 | 07:02 ET | [8-K](/filings/0001628280-25-013984.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-013984 |
| 2025-01-13 | 07:07 ET | [8-K](/filings/0001628280-25-001228.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-001228 |
| 2025-01-02 | 07:04 ET | [8-K](/filings/0001628280-25-000005.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-000005 |
| 2024-12-05 | 07:03 ET | [8-K](/filings/0001628280-24-049979.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-24-049979 |
| 2024-11-12 | 07:30 ET | [8-K](/filings/0001628280-24-046852.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-24-046852 |
| 2024-11-07 | 07:04 ET | [10-Q](/filings/0001628280-24-045965.md) | Quarterly report, period 2024-09-30 | 0001628280-24-045965 |
| 2024-11-07 | 07:02 ET | [8-K](/filings/0001628280-24-045964.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-045964 |
| 2024-10-08 | 07:13 ET | [8-K](/filings/0001628280-24-042478.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-24-042478 |
| 2024-09-09 | 07:22 ET | [8-K](/filings/0001628280-24-039764.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-24-039764 |
| 2024-09-04 | 07:01 ET | [8-K](/filings/0001628280-24-039221.md) | 8.01 Other events | 0001628280-24-039221 |
| 2024-08-14 | 16:01 ET | [8-K](/filings/0001628280-24-037174.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001628280-24-037174 |
| 2024-08-12 | 07:03 ET | [10-Q](/filings/0001628280-24-036591.md) | Quarterly report, period 2024-06-30 | 0001628280-24-036591 |
| 2024-08-12 | 07:01 ET | [8-K](/filings/0001628280-24-036589.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-036589 |
| 2024-07-30 | 16:01 ET | [8-K](/filings/0001628280-24-033437.md) | 8.01 Other events | 0001628280-24-033437 |

Page 1 of 7. [Older](/companies/avtx/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 16:18 ET. No prices; not investment advice.